Noninvasive diagnosis of cardiac amyloidosis by MRI and echochardiography

SummaryThis study described the radiological features on echocardiography and MRI specific to cardiac amyloidosis confirmed on biopsy. Eleven cases of biopsy-proven cardiac amyloidosis were retrospectively reviewed in this study. All patients underwent biopsy, cardiac MRI and echocardiography. The main echocardiography and MRI findings were as follows: diffuse ventricular and septum wall thickening, atrial enlargement, pericardial effusion, restricted left ventricular (LV) systolic and diastolic function, characteristic granular sparkling of myocardium. MRI revealed a characteristic pattern of global subendocardial late enhancement, extending in varying degrees into the neighboring myocardium. The findings agreed with the infiltration distribution of amyloid protein. Typical abnormalities seen on echocardiography and MRI should have important diagnostic and prognostic value of cardiac amyloidosis. MRI should be considered in the diagnosis of cardiac amyloidosis if echocardiographic features are suspicious.

[1]  Richard E Thompson,et al.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. , 2004, Journal of the American College of Cardiology.

[2]  R. Falk,et al.  Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. , 1987, The American journal of cardiology.

[3]  J. Seward,et al.  M‐mode and Two‐dimensional Echocardiographic Features in Cardiac Amyloidosis , 1981, Circulation.

[4]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[5]  V. Sanchorawala Light-chain (AL) amyloidosis: diagnosis and treatment. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[6]  Keyur B Shah,et al.  Amyloidosis and the heart: a comprehensive review. , 2006, Archives of internal medicine.

[7]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[8]  A. Tajik,et al.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. , 2005, The American journal of cardiology.

[9]  K. Kubo,et al.  Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. , 2000, The American journal of cardiology.

[10]  H. Goldschmidt,et al.  Non‐invasive predictors of survival in cardiac amyloidosis , 2007, European journal of heart failure.

[11]  S. Neubauer,et al.  Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging. , 2006, International journal of cardiology.

[12]  R. Falk,et al.  The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. , 1998, QJM : monthly journal of the Association of Physicians.

[13]  R. Falk,et al.  Cardiovascular magnetic resonance in cardiac amyloidosis. , 2005, Circulation.

[14]  I. Sakamoto,et al.  Cardiac Amyloidosis: Typical Imaging Findings and Diffuse Myocardial Damage Demonstrated by Delayed Contrast-Enhanced MRI , 2006, CardioVascular and Interventional Radiology.

[15]  W. Strugnell,et al.  MR findings in cardiac amyloidosis. , 2006, AJR. American journal of roentgenology.

[16]  R. Falk Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[17]  F. Salvi,et al.  Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance , 2005, Heart.

[18]  A J Tajik,et al.  Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. , 1996, Journal of the American College of Cardiology.